Jubilant Ingrevia Limited
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
What Jubilant files
- Others85
- Important54
- Investor Meet39
- Updates38
- Dividend/Bonus21
- QIP/Rights/Pref.21
Jubilant Ingrevia's 7th AGM approved all resolutions, including the adoption of FY26 standalone and consolidated financial results. Shareholders also declared a final dividend of Rs. 2.50 per equity share, totaling approximately Rs. 39.82 Cr.
Jubilant Ingrevia is acquiring a 40% strategic stake in Zettaone Technologies, an electronics design and manufacturing platform, for ₹189.2 Cr. This move expands its presence in Electronics Development and Manufacturing Services (EDMS), aligning with its Pinnacle growth strategy and strengthening its electronics/semiconductor value chain.
Jubilant Ingrevia acquires a 40% strategic stake in Zettaone Technologies for ₹189.2 Cr. This move expands its footprint into Electronics Development & Manufacturing Services (EDMS) and the semiconductor sector, leveraging existing CDMO capabilities.
Jubilant Ingrevia announced its 7th Annual General Meeting (AGM) will be held virtually. Shareholders whose emails aren't registered can access the Annual Report and AGM notice through company website links. Information on virtual participation and e-voting is available.
Jubilant Ingrevia's Board proposed a final dividend of ₹2.50/share for FY26, subject to AGM approval. Shareholders on record date July 24, 2026, will be eligible. Tax will be withheld at source, with varying rates and exemptions for resident individuals up to ₹10,000.